+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07662356

Clinical Study of NAFLD and Biomarkers in Obese Chinese Adults Undergoing Bariatric Surgery to Understand Liver Disease Progression

Led by Chinese University of Hong Kong · Updated on 2026-06-23

200

Participants Needed

1

Research Sites

114 weeks

Total Duration

AI-Summary

What This Trial Is About

Nonalcoholic fatty liver disease NAFLD is a common chronic liver condition that can progress to nonalcoholic steatohepatitis NASH, cirrhosis, and liver cancer. This research aims to better understand the clinical course and biomarkers related to NAFLD in obese Chinese adults undergoing bariatric surgery. The study addresses knowledge gaps about how NAFLD develops and progresses, and how to predict and treat it effectively. Participants in this observational study are obese patients, some with NAFLD and some without, who undergo laparoscopic bariatric surgery. During surgery, liver biopsies are taken for detailed tissue analysis to assess the presence and severity of NAFLD and NASH. Clinical and biochemical evaluations are performed before and after surgery to track changes over time. Participants will be closely monitored to determine the prevalence of NAFLD and NASH at the start and after one year. Researchers will examine clinical features and biomarkers that predict disease progression and correlate blood test results with liver tissue findings. The total follow-up period includes assessments at baseline and one year, focusing on disease characteristics and potential indicators for NAFLD and NASH.

CONDITIONS

Brief Title

Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity

Research Team

A

Alice Pik Shan Kong, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here